Synergistic anti-tumor activity, reduced pERK, and immuno-stimulatory cytokine profiles with 5-FU or ONC212 plus KRAS G12D inhibitor MRTX1133 in CRC and pancreatic cancer cells independent of G12D mutation
Vida Tajiknia(John Brown University), Wafik S. El‐Deiry(Fox Chase Cancer Center)
Cited by 1
Related Papers
Deficient Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL) Death Receptor Transport to the Cell Surface in Human Colon Cancer Cells Selected for Resistance to TRAIL-induced Apoptosis
|Journal of Biological Chemistry|2004|232
Identification of Inhibitors of TRAIL-induced Death (ITIDs) in the TRAIL-sensitive Colon Carcinoma Cell Line SW480 Using a Genetic Approach
|Journal of Biological Chemistry|2001|155
Phosphorylation of p21 in G<sub>2</sub>/M Promotes Cyclin B-Cdc2 Kinase Activity
|Molecular and Cellular Biology|2005|131
Application of 3D tumoroid systems to define immune and cytotoxic therapeutic responses based on tumoroid and tissue slice culture molecular signatures
|Oncotarget|2017|131
Dose intensification of TRAIL-inducing ONC201 inhibits metastasis and promotes intratumoral NK cell recruitment
|Journal of Clinical Investigation|2018|80